JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansuy, J. M.
Right arrow Articles by Izopet, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansuy, J. M.
Right arrow Articles by Izopet, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2004, p. 912-913, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.912-913.2004
Copyright © 2004, American Society of Microbiology. All Rights Reserved.

Immunologically Silent Autochthonous Acute Hepatitis E Virus Infection in France

Jean Michel Mansuy,1* Jean Marie Peron,2 Christophe Bureau,2 Laurent Alric,3 Jean Pierre Vinel,2 and Jacques Izopet1

Virology Laboratory,1 Department of Hepato-Gastro-Enterology,2 Department of Internal Medicine, Purpan University Hospital, 31059 Toulouse, France3

Received 5 August 2003/ Returned for modification 12 October 2003/ Accepted 4 November 2003


    ABSTRACT
 Top
 Abstract
 Case report
 References
 
Hepatitis E is an acute and self-limiting hepatitis, and the causative agent, hepatitis E virus, is excreted in feces and orally transmitted. The disease is common in Asia and Africa, causing outbreaks or sporadic cases. In Europe, the infection is generally observed after a history of travel in an area of endemicity. We report on an autochthonous case in southwestern France in which the diagnosis was based on molecular tools rather than serological testing.


    CASE REPORT
 Top
 Abstract
 Case report
 References
 
In summer 2002, a 41-year-old woman without any medical or surgical history was admitted to the Toulouse University Hospital having suffered jaundice and fever for 2 days. On examination, the patient was subfebrile (37.8°C) and icteric. Her abdomen was pliant and painless. The liver was normal, there was a little splenomegaly, and no symptom of hepatic insufficiency was noted. Biochemical investigations revealed a marked hepatic cytolysis: serum alanine aminotransferase, bilirubin, and gamma-glutamyltransferase levels were 5,126 IU/liter (170 N), 40 µmol/liter (2.3 N), and 320 IU/liter (9.1 N), respectively. Hematological investigations revealed a hemoglobin level of 12.3 g/dl, a platelet count of 89 x 109/liter, and a white cell count of 5.8 x 109/liter. The prothrombin index was 76%, and the C-reactive protein level was 46 mg/liter. The abdominal ultrasonograph was normal. Toxin or drug causality was ruled out after questioning. The patient lived in an urban setting in the Midi Pyrénées area (southwest France) and was a teacher. Her hobby was gardening. She had not traveled outside France during the previous 6 months, and the only livestock near her house were poultry. In view of the fever, blood and urine cultures were taken and remained sterile. The serum was negative for hepatitis B virus antigen and DNA, hepatitis B virus core antibodies, hepatitis C virus RNA and antibodies, immunoglobulin M antibodies to hepatitis A virus, cytomegalovirus, and Epstein-Barr virus.

The assay for hepatitis E virus (HEV) immunoglobulin G (IgG) antibodies was negative with a ratio of 0.57 (optical density/cutoff ratio, positive if >1) according to the only serological test commercially available in France (HEV enzyme immunoassay; Abbott Laboratories, Rungis, France). Nevertheless, HEV infection was diagnosed using molecular tools (real-time PCR with Taqman detection amplifying a 189-bp product located in the ORF2 region) on icteric-phase serum and stools.

The strain was sequenced and compared with reference HEV strains (GenBank) and local controls. The resulting phylogenetic analysis (Fig. 1) demonstrated the propinquity between our strain and other HEV strains previously identified in patients with acute hepatitis living in the Midi Pyrénées area. All of the strains from Midi Pyrénées belonged to genotype III.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 1. Phylogenetic analysis of the 189-bp ORF2 region product ("PATIENT"). The designations MP1 to MP9 represent locations of strains previously found in patients from the Midi Pyrénées region.

 
The patient recovered completely after a short period of hospital care, and her serum alanine aminotransferase, bilirubin, and gamma-glutamyltransferase levels returned to normal within a month. The HEV IgG assay remained negative 4 months later (ratio = 0.36).

Most cases of HEV infection in France are contracted in areas of endemicity, and autochthonous cases are scarce. Nicand et al. (4) described family cases with HEV viremia and no HEV antibodies. But these differed from our case in that they had no clinical or laboratory symptoms, suggesting that there was a human HEV reservoir. Our patient had not recently traveled outside France, even to Spain, where autochthonous cases have been recently reported (5).

To the best of our knowledge, this is the first reported case of acute HEV infection diagnosed using molecular tools alone. The possibility of a serological window was discarded because there was no HEV IgG in a serum sample collected 4 months later. The insensitivity of certain enzyme immunoassays has also been noted by others (1), making the design of more sensitive immunological tests mandatory.

The mode of transmission remains unclear. HEV has been found in poultry in the United States (2) and in swine in the United States (2), Spain (5), and The Netherlands (7). Various other domestic (3) or wild (6) animals harbor the virus. This indicates that the virus could be more widespread than was previously thought.

We suggest that HEV infection be routinely considered in cases of acute non-A, -B, -C, and -D hepatitis, even in patients who have not traveled in areas of endemicity. Molecular tools could be very useful complements to conventional serological tests.

Larger studies are now required to evaluate the incidence of human HEV infection in areas that are nonendemic and to identify any animal reservoirs of the virus.


    FOOTNOTES
 
* Corresponding author. Mailing address: Virology Laboratory, Purpan University Hospital, 31059 Toulouse, France. Phone: 33 5 61 77 22 65. Fax: 33 5 61 77 25 42. E-mail: mansuy.jm{at}chu-toulouse.fr. Back


    REFERENCES
 Top
 Abstract
 Case report
 References
 

  1. Christensen, P. B., R. E. Engle, S. E. Jacobsen, H. B. Krarup, J. Georgsen, and R. H. Purcell. 2002. High prevalence of hepatitis E antibodies among Danish prisoners and drug users. J. Med. Virol. 66:49-55.[Medline]
  2. Haqshenas, G., H. L. Shivaprasad, P. R. Woolcock, D. H. Read, and X. J. Meng. 2001. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J. Gen. Virol. 82:2449-2462.[Abstract/Free Full Text]
  3. Kuno, A., K. Ido, N. Isoda, et al. 2003. Sporadic acute hepatitis E of a 47-year-old man whose pet cat was positive for antibody to hepatitis E virus. Hepatol. Res. 26:237-242.[CrossRef][Medline]
  4. Nicand, E., M. Grandadam, R. Teyssou, J. L. Rey, and Y. Buisson. 2001. Viraemia and faecal shedding of HEV in symptom-free carriers. Lancet 357:68-69.[CrossRef]
  5. Pina, S., M. Buti, M. Cotrina, J. Piella, and R. Girones. 2000. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J. Hepatol. 33:826-833.[CrossRef][Medline]
  6. Tei, S., N. Kitajima, K. Takahashi, and S. Mishiro. 2003. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362:371-373.[CrossRef][Medline]
  7. van der Poel, W. H., F. Verschoor, R. van der Heide, et al. 2001. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg. Infect. Dis. 7:970-976.[Medline]


Journal of Clinical Microbiology, February 2004, p. 912-913, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.912-913.2004
Copyright © 2004, American Society of Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansuy, J. M.
Right arrow Articles by Izopet, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansuy, J. M.
Right arrow Articles by Izopet, J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS